← Open Payments lookup

AMANDA THOMPSON: Open Payments

NPI 1891129854 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,188 in 93 payments from 9 companies in 2025. Trend: 2023 $1,021 · 2024 $918 · 2025 $2,188

Food & beverage: $2,188
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.24$495
Janssen Pharmaceuticals, Inc10$427
E.R. Squibb & Sons, L.L.C.11$356
Alkermes, Inc.16$249
Vanda Pharmaceuticals Inc.8$205
Otsuka America Pharmaceutical, Inc.9$169
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$165
Teva Pharmaceuticals USA, Inc.3$64
ABBVIE INC.3$57

Products named: INGREZZA, INVEGA SUSTENNA, COBENFY, FANAPT, CAPLYTA, ARISTADA, REXULTI, VIVITROL.

Industry payments across CA — which companies pay providers there.